🇺🇸 🇪🇺 US—EU Trade Framework of 21 August 2025 changes existing tariffs, potentially reshapes global supply chains to expand market access and enhance #trade and #investment. US tariffs on EU #pharmaceuticals shall not exceed 15%.
https://t.co/F6oguTNXDg
The #EU is undertaking its most significant reform of #pharmaceutical legislation in two decades, targeted at advancing the #lifesciences industry, and supporting #healthcare systems.
https://t.co/2KmUb0JWp6
Full article: https://t.co/OilJifAtkq
An examination of legal and practical issues surrounding the pricing and reimbursement of medicinal products and medical devices in Malta.
https://t.co/iWmfJ6ur1q
The chapter I authored in The Life Sciences Law Review (Edition 10) published in 2022 is an overview of the legal and regulatory frameworks governing pharmaceutical, biotechnology, and medical device companies in Malta #pharmaceutical#regulatory#law
https://t.co/VqVdpdwSRB
Happy World Heart Day to Professor Jane Somerville who made it possible for so many tiny hearts to become big hearts ❤️ @_thesf
https://t.co/GNi75KVo0M
#WorldHeartDay
I was presented the eighth Edition of the book ‘The Life Science Law Review’ by Dr Anthia A. Zammit. We shared views about the need to look at medicine through a human lens and to protect a system that puts the interest and health of the patient above any economic interest.
✅@Europarl_EN & @EUCouncil adopt our proposal to postpone the application of the Medical Devices Regulation
Fighting the #coronavirus pandemic is our top priority including through availability of medical devices & patient safety
More: https://t.co/PeI9jYNM6I
#StrongerTogether
“Judging one person by a different set of rules than another is an insidious form of corruption that undermines the meritocracy.”—@RayDalio, American billionaire investor and founder of one of the world's largest hedge funds. Ranked world's 58th wealthiest person by Bloomberg
In some companies, employees hide their employer’s mistakes, and employers do the same in return. This stands in the way of improvement, preventing people from bringing their mistakes and weaknesses to the surface, encourages deception, & eliminates subordinates’ right of appeal.
EMA and @US_FDA are aligned in > 90% of marketing authorisation decisions for new #medicines 💊, as shown by joint analysis of 107 new medicine authorisations from 2014 to 2016:
👉https://t.co/PSAmNHCDAy